AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017
Mar 24, 2017
30583_dirs_2017-03-24_067b081f-71f2-4b3d-8579-1cbecad5bf8e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-03-22
Reporting Person: FUCHS HENRY J (President, Worldwide R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-22 | Common Stock | A | 19790 | — | Acquired | 140192 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-22 | Stock Option (Right to buy Common Stock) | $87.42 | A | 64030 | Acquired | 2027-03-21 | Common Stock (64030) | Direct |
Footnotes
F1: Restricted stock units granted on March 22, 2017. Price not applicable.
F2: Option grant vests 12/48th on March 22, 2018 and 1/48th on the 22nd day of each month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19